Source link : https://yourblogdomain.com/2025/12/09/bispecific-trial-in-myeloma-sparks-talks-of-functional-cure/
Source link : https://newshealth.biz/health-news/bispecific-trial-in-myeloma-sparks-talks-of-functional-cure/ (MedPage Today) — ORLANDO — Combining teclistamab (Tecvayli) with subcutaneous daratumumab-hyaluronidase (Darzalex Faspro) significantly improved progression-free survival (PFS) and overall survival (OS) in patients with relapsed/refractory… Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118914 Author : Publish date : 2025-12-09 19:35:00 Copyright for syndicated content belongs to the linked Source. The post Bispecific Trial in […]
—-
Author : yourblogdomain
Publish date : 2025-12-09 21:02:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8